PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-24.09%
Both companies show declining cash positions (-24.09% vs AXSM's -12.55%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-24.09%
Cash + STI yoy ≥ 1.5x AXSM's -12.55%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.04%
≥ 1.5x AXSM's -12.93%. David Dodd might see a short-term liquidity advantage or potential underutilized capital.
-17.11%
Below half AXSM's 209.04%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.78%
Below half of AXSM's 79.16%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
-19.98%
≥ 1.5x AXSM's -12.72%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
86.42%
Above 1.5x AXSM's 27.43%. Michael Burry questions if payables are being stretched to avoid short-term borrowing.
-100.00%
Higher Short-Term Debt Growth compared to AXSM's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both AXSM and the company show zero Deferred Revenue (Current) Growth.
-55.20%
Higher Other Current Liabilities Growth compared to AXSM's zero value, indicating worse performance.
21.67%
50-75% of AXSM's 31.98%. Bruce Berkowitz notes the firm keeps current liabilities growth relatively low.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.67%
50-75% of AXSM's 31.98%. Bruce Berkowitz notes a lower yoy liability increase.
0.96%
Higher Common Stock (Book Value) Growth compared to AXSM's zero value, indicating worse performance.
-5.35%
Below half AXSM's -21.72%. Michael Burry suspects major net losses or high dividends vs. competitor.
-15.38%
Higher AOCI Growth compared to AXSM's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
-25.41%
1.25-1.5x AXSM's -19.26%. Bruce Berkowitz notes an above-average equity expansion.
-19.98%
≥ 1.5x AXSM's -12.72%. David Dodd sees faster overall balance sheet growth than competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Higher Total Debt Growth compared to AXSM's zero value, indicating worse performance.
23.76%
Above 1.5x AXSM's 12.55%. Michael Burry sees a major gap in net debt growth. Check coverage and liquidity.